SUJIN LEE: Open Payments
NPI 1053980383 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 4 payments from 4 companies in 2025. Trend: 2023 $159 · 2024 $682 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 1 | $151 |
| Novo Nordisk Inc | 1 | $125 |
| Madrigal Pharmaceuticals | 1 | $122 |
| Tandem Diabetes Care, Inc. | 1 | $104 |
Products named: Korlym, Ozempic, REZDIFFRA, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across AZ — which companies pay providers there.
